loading
AdvertisementX
AdvertisementX

North America

AquaBounty in talks for royalty deal as FDA approval clears pathway to growth

AquaBounty, having obtained key FDA approval for its genetically modified salmon, is speaking to potential partners to fast-track the growth of the fish around the world

By Matt Craze | July 9, 2018 16:20 BST
AquaBounty GM salmon
In the background, AquaBounty's genetically modified salmon showcases its accelerated growth, surpassing the size and speed of a conventional Atlantic salmon of the same age in the foreground. Credit: AquaBounty
AdvertisementX

Contact the author [email protected]

Stay on the pulse

Get recommendations, data, editor’s picks, and the latest news from around the seafood world straight to your inbox.

Select your interests

Please select at least one newsletter d indicates our daily newsletters | 2w indicates twice-weekly | All others sent weekly All briefings are sent weekly, unless otherwise indicated
Region
Breaking news
Jobs
Species
Topic

Fill in your details

Please select at least one newsletter!
  • (eg new industry reports, prices data)
  • (eg subscription or report early birds)
  • (eg advertising, trade shows news)
Thank you. Please check your inbox to confirm your selection and start receiving newsletters.

Cookies on Undercurrent News

We use cookies for performance, security and analytics. To stop seeing this banner click Accept, or select Manage cookies to set your preferences and privacy settings.